Literature DB >> 8113994

HOE-234, a second generation K+ channel opener, antagonizes the ATP-dependent gating of cardiac ATP-sensitive K+ channels.

A Terzic1, A Jahangir, Y Kurachi.   

Abstract

Effects of (3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-6- phenylsulfonylchroman hemihydrate (HOE-234), a novel dilator of bronchial and vascular smooth muscles, were examined on whole-cell and single channel currents in guinea pig cardiomyocytes. Under the whole-cell voltage-clamp condition, HOE-234 (0.6-100 microM) induced a time-independent K(+)-dominant current in atrial and ventricular myocytes. This current was inhibited by glyburide, a selective blocker of ATP-sensitive K+ (KATP) channels, suggesting that HOE-234 activates KATP channels. Neither intracellular acidification nor the absence of intracellular ADP inhibited the ability of HOE-234 to induce the current. In inside-out membrane patches in the presence of 200 microM ATP, HOE-234 (0.3-10 microM) increased concentration dependently (EC50 approximately 1 microM) the KATP channel activity. In the absence of HOE-234, half-inhibition of spontaneously operative KATP channels occurred at 25 microM of intracellular ATP (ATPi), whereas in the presence of HOE-234 (10 microM), 316 microM of ATPi was required for half-inhibition. In ATP-free internal solution, KATP channels appeared and then ran down. In the absence of ATPi, HOE-234 did not increase channel activity when channels were in a fully open or in the partially or completely run-down state. After run-down, the nucleoside diphosphate, UDP, restored KATP channel activity which was not further augmented by HOE-234. However, HOE-234 relieved at ATP- or ATP gamma S-mediated inhibition of the UDP-induced KATP channel activity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8113994

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

Review 1.  K(ATP) channel therapeutics at the bedside.

Authors:  A Jahangir; Andre Terzic
Journal:  J Mol Cell Cardiol       Date:  2005-07       Impact factor: 5.000

2.  The novel cardioprotective agent BMS-180448 activates a potassium conductance in cardiac and vascular smooth muscle.

Authors:  N J Lodge; M A Smith
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

3.  Ligand-insensitive state of cardiac ATP-sensitive K+ channels. Basis for channel opening.

Authors:  A E Alekseev; P A Brady; A Terzic
Journal:  J Gen Physiol       Date:  1998-02       Impact factor: 4.086

4.  The molecular basis of the specificity of action of K(ATP) channel openers.

Authors:  C Moreau; H Jacquet; A L Prost; N D'hahan; M Vivaudou
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

5.  The new antihypertensive drug iptakalim activates ATP-sensitive potassium channels in the endothelium of resistance blood vessels.

Authors:  Su-yang Wang; Wen-yu Cui; Hai Wang
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

6.  Adenosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rilmakalim.

Authors:  E Krause; H Englert; H Gögelein
Journal:  Pflugers Arch       Date:  1995-03       Impact factor: 3.657

7.  Mechanism of action of K channel openers on skeletal muscle KATP channels. Interactions with nucleotides and protons.

Authors:  C Forestier; J Pierrard; M Vivaudou
Journal:  J Gen Physiol       Date:  1996-04       Impact factor: 4.086

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.